# Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)

> **NCT00961233** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 25 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** inhaled/swallowed budesonide
- **DRUG:** viscous/swallowed budesonide

## Key facts

- **NCT ID:** NCT00961233
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-08
- **Final completion:** 2011-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2012-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00961233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00961233, "Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00961233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*